510(k) Report

FDA applicant

Medtronic Neuromodulation

Minneapolis5 decisions1984–202514 recalls

FDA records 5 decisions for Medtronic Neuromodulation (Minneapolis) from 1984 to 2025: 1 De Novo grant and 4 original PMA approvals. Most are in product codes EZW (Stimulator, Electrical, Implantable, For…) and QPT (Stimulator, Tibial, Electrical, Implantable…). 14 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Medtronic Neuromodulation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2011: 12021: 12025: 1
2007high 1 (2011) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2025

2007: 22013: 12014: 12015: 12016: 12021: 12022: 12023: 22024: 22025: 1
2007high 2 (2007) · low 0 (2008)2026

Class I Class II/III not classified

FIG. 1 — Medtronic Neuromodulation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Medtronic Neuromodulation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report